Influenza News and Research

Latest Influenza News and Research

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

The vital role of smartphone apps during the COVID-19 pandemic

At the start of the coronavirus disease 2019 (COVID-19) pandemic, analog techniques like nasopharyngeal swab specimens for polymerase chain reaction (PCR) testing were prominent. The widespread use of nonpharmaceutical interventions (NPIs) such as facemasks and social distancing was reminiscent of the influenza outbreak in 1918.

9 Jul 2023

Cheers or caution? Researchers question the potential benefits of alcohol consumption

Research paper discusses the relationship between alcohol consumption and health, specifically the J-shaped association. While some studies suggest this relationship, recent studies challenge it due to limitations in study design and individual variability. The paper also emphasizes the importance of considering alternative health-promoting strategies and societal/population-level harmful effects of alcohol use.

9 Jul 2023

Wastewater monitoring can be an effective tool for global disease surveillance

Wastewater monitoring could act as an early warning system to help countries better prepare for future pandemics, according to a new study.

6 Jul 2023

Moderna COVID-19 vaccine effective in children five and under

mRNA-1273 vaccine (Moderna) shows strong effectiveness in reducing symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. Further research is needed to explore long-term effectiveness and the potential need for booster doses.

5 Jul 2023

Danish researchers solve puzzle of how hepatitis C virus evades immune system

With a new method for examining virus samples researchers from the University of Copenhagen have solved an old riddle about how Hepatitis C virus avoids the human body's immune defenses.

5 Jul 2023

A novel RSV vaccine that could be effective across all ages

Researchers evaluate the in vivo efficacy of a respiratory syncytial virus vaccine in old and young rats.

4 Jul 2023

Multiple drug targets for the treatment of influenza identified using AI program

Poolbeg Pharma, a clinical-stage biopharmaceutical company focusing on infectious and other prevalent diseases with a high unmet medical need, announces a significant breakthrough in its world first influenza Artificial Intelligence ('AI') Programme with CytoReason.

1 Jul 2023

Advances in influenza research

This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in influenza research and how effective vaccines are developed.

From Sino Biological Inc. 30 Jun 2023

Understanding the biological effects of SARS-CoV-2 persistence in children

Researchers analyzed the most recent knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Jun 2023

Public health concerns as highly pathogenic avian influenza A(H5N1) virus found in cat in France

Study describes the identification of a highly pathogenic avian influenza A virus in a domestic cat.

28 Jun 2023

Hybrid immunity and vaccine Imprinting: Powerful defenses against Omicron reinfection

Recent research explores the impact of hybrid immunity and vaccine-only imprinting on omicron reinfection. Findings suggest effective protection and immune response in a long-term imprinted population.

25 Jun 2023

Key viral protein produced by influenza A can shred a host cell's genetic materials, finds study

Influenza A is one of two influenza viruses that fuel costly annual flu seasons and is a near constant threat to humans and many other animals. It's also responsible for occasional pandemics that, like the one in 1918, leave millions dead and wreak havoc on health systems and wider society.

23 Jun 2023

Influenza News and Research

Latest Influenza News and Research

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

The vital role of smartphone apps during the COVID-19 pandemic

Cheers or caution? Researchers question the potential benefits of alcohol consumption

Wastewater monitoring can be an effective tool for global disease surveillance

Moderna COVID-19 vaccine effective in children five and under

Danish researchers solve puzzle of how hepatitis C virus evades immune system

A novel RSV vaccine that could be effective across all ages

Multiple drug targets for the treatment of influenza identified using AI program

Advances in influenza research

Understanding the biological effects of SARS-CoV-2 persistence in children

Public health concerns as highly pathogenic avian influenza A(H5N1) virus found in cat in France

Hybrid immunity and vaccine Imprinting: Powerful defenses against Omicron reinfection

Key viral protein produced by influenza A can shred a host cell's genetic materials, finds study

Plant based compound peruvoside may be able to prevent up to 12 medically important viruses

Unmasking the threat: Scientists show how climate change fuels viral respiratory infections

Exposure to air pollution associated with COVID-19 disease severity

Study describes health outcomes following simultaneous vaccination with monovalent primary series COVID-19 vaccines

Is Guillain-Barré syndrome induced by SARS-CoV-2 vaccination?

Researchers review the principles of universal vaccine development for key pandemic potential viruses

Trained immunity: its role in COVID-19 and potential in preparing for future infectious outbreaks

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Influenza News and Research

Latest Influenza News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in